Filing Details
- Accession Number:
- 0001170316-23-000002
- Form Type:
- 13G Filing
- Publication Date:
- 2023-02-13 19:00:00
- Filed By:
- Singer James R
- Company:
- Verve Therapeutics Inc.
- Filing Date:
- 2023-02-14
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| James R. Singer | 5,000,000 | 5,000,000 | 5,000,000 | 8.1% |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* VERVE THERAPEUTICS INC (Name of Issuer) COMMON STOCK (Title of Class of Securities)92539P101 (CUSIP Number)DECEMBER 31, 2022 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d)*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Item 1(a). Name of Issuer: VERVE THERAPEUTICS INC Item 1(b). Address of Issuer's Principal Executive Offices: 500 Technology Square, Suite 901 Cambridge, MA 02139 US Item 2(a). Name of Person Filing: The person filing this report is James R. Singer. Item 2(b). Address of Principal Business Office or, if none, Residence: PO Box 1395, Yarmouth, ME 04096 Item 2(c). Citizenship: United States of America Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 92539P101Item 3. Statements filed pursuant to rules 13D-1(b) or 13D-2(B) or (C) Not applicable Item 4. Ownership. The information set forth in Rows 5 through 9 and 11 of the cover pages of this Schedule 13G is incorporated herein by reference. Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable.SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 1, 2023 Date /S/James R. Singer Signature JAMES R. SINGER Name/Title